Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
50.34
-1.59 (-3.06%)
Mar 13, 2026, 3:29 PM EST
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$773,849
Profits / Employee
$157,320
Market Cap
323.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Tian'an Technology Group | 8 |
Roche Holding AG News
- 2 days ago - Harbor Health Care ETF Q4 2025 Portfolio Review - Seeking Alpha
- 3 days ago - Roche Annual General Meeting 2026 - GlobeNewsWire
- 3 days ago - Glooko to Expand EMEA CGM Connectivity with Roche Accu-Chek® SmartGuide Integration - Business Wire
- 3 days ago - Roche Holding AG (RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline Transcript - Seeking Alpha
- 4 days ago - Roche shares drop as oral breast cancer drug fails in trial - Reuters
- 4 days ago - Roche Breast-Cancer Treatment Falls Short of Primary Goal in Late-Stage Study - WSJ
- 4 days ago - Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer - Business Wire
- 4 days ago - [Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer - GlobeNewsWire